1). In mice, targeted deletion of Sh2b1 results in marked leptin resistance, increased food intake, severe obesity, and insulin resistance. An intermediate obesity phenotype is seen in heterozygous null mice fed a high-fat diet (2, 3), suggesting that the obesity phenotype is dosage dependent. Here, SH2B1 is linked to obesity disorder.